Table 2.
Underestimation of invasive cancer in comparison with concomitant benign changes diagnosed together with ADH during biopsy.
| Concomitant changes diagnosed with ADH on biopsy | Noninvasive change, n = 122 | Underestimation of invasive cancer, n = 12 | p value |
|---|---|---|---|
| CCH | 11 (9%) | 1 (8.3%) | 0.94 |
| CCC | 6 (4.9%) | 0 | 0.43 |
| UDH | 43 (35.3%) | 5 (50%) | 0.58 |
| Adenosis simplex | 11 (9%) | 0 | 0.28 |
| Mastopatia | 74 (60.6%) | 5 (41.7%) | 0.2 |
| Mikrozwapnienia | 98 (80.3%) | 8 (66.7%) | 0.27 |
| Adenosis sclerosans | 69 (56.6%) | 7 (58.3%) | 0.9 |
| Lipomatosis | 18 (14.8%) | 0 | 0.15 |
| Fibroadenoma | 8 (6.56%) | 0 | 0.36 |